We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Johnson & Johnson | LSE:0R34 | London | Ordinary Share | JOHNSON & JOHNSON ORD (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 147.20 | 147.20 | 157.60 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1,102 | 14:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 85.16B | 35.15B | 14.6028 | 10.47 | 354.35B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/1/2025 | 12:03 | ALNC |  Johnson & Johnson reports sales growth following "transformative year" |
| 13/1/2025 | 12:36 | ALNC | J&J acquires schizophrenia drug in USD14.6 billion Intra-Cellular deal |
| 20/11/2024 | 14:13 | ALNC | Johnson & Johnson risks UK lawsuit over talc cancer claim |
| 15/10/2024 | 11:36 | ALNC | TOP NEWS: Johnson & Johnson ups sales outlook but cuts profit guide |
| 09/10/2024 | 18:36 | ALNC | TOP NEWS: J&J USD600 million V-Wave purchase to cut earnings per share |
| 20/8/2024 | 12:12 | ALNC | J&J to pay up to USD1.7 billion for heart failure device firm V-Wave |
| 17/7/2024 | 11:25 | ALNC | TOP NEWS: Johnson & Johnson touts "robust pipeline" as sales rise |
| 31/5/2024 | 13:30 | ALNC | Johnson & Johnson ties up acquisition of Shockwave Medical |
| 01/5/2024 | 13:17 | ALNC | TOP NEWS: J&J proposes USD6.48 billion settlement of cancer lawsuits |
| 16/4/2024 | 10:54 | ALNC | TOP NEWS: Johnson & Johnson upgrades guidance on swing to earnings |
1 Year Johnson & Johnson Chart |
Intraday Johnson & Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
